Aristotle University Of Thessaloniki (AUTH)
Μελέτη της ενεργοποίησης του συμπληρώματος σε ενήλικες ασθενείς με δρεπανοκυτταρική νόσο
Abstract
dc:descriptionSickle cell disease (SCD) is a common inherited hemoglobinopathy, characterized by hemoglobin S. Anemia, susceptibility to infections and episodes of vaso-occlusive crisis (VOC) are among its features. Since SCD complications (VOC or delayed hemolytic transfusion reaction/DHTR) lead to significant morbidity and mortality, a number of studies has addressed their pathophysiology Although SCD pathophysiology has been mainly attributed to the interaction between sickle cells and neutrophils, platelets or endothelial cells in small vessels leading to hemolysis, the role of complement activation has been increasingly investigated. Despite these advances there is still no specific treatment for the disease’s complications. It was hypothesized that complement activation and thromboinflammation are evident in SCD, especially during complications, with the investigation of novel biomarkers or genetic features. SCD patients’ samples were prospectively studied at enrolment, any disease update or last follow-up. Complement activation was detected by using sC5b-9 and the modified Ham test, while ADAMTS 13 activity and Neutrophil Extracellular Traps (NETs) with ELISA. This study utilized next generation sequencing analysis with a customized panel (CFH, CFH-related, CFI, CFB, CFD, C3, CD55, C5, CD46, THBD, ADAMTS13). Among 81 patients, we detected complement activation (C5b-9, positive modified Ham test) and increased NETs even from steady state in those that then developed complications. During follow-up, C5b-9 increased significantly, particularly in patients with complications. There were no differences in ADAMTS13 activity. Twenty-five rare variants were detected, 3 of which were characterized as pathogenic in 3 patients, and 5 as deleterious in 12 patients. Patients with pathogenic or deleterious variants had increased complement activation. Combination of these variants was associated with significantly higher transfusion dependency rate. In multivariate analysis, C5b-9 levels were independent predictors of complications. In conclusion, it was shown prospectively for the first time that complement and NETs are activated even from steady state in patients with complications, especially during complications. Complement-related variants underline this predisposition in certain patients. Considering safety and efficacy of complement inhibitors, our study highlights useful tools to early detect patients that might benefit from complement inhibition.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2024
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Varelas, Christos
- Βαρελάς, Χρήστος
Subjects
dc:subject × 8Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/55925